BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2165413)

  • 1. Vimentin as a marker of myoepithelial cells in salivary gland tumors.
    de Araújo VC; de Araújo NS
    Eur Arch Otorhinolaryngol; 1990; 247(4):252-5. PubMed ID: 2165413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study.
    de Araujo VC; Carvalho YR; de Araujo NS
    Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):387-91. PubMed ID: 8015803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of vimentin, calponin and HHF-35 in salivary gland tumors.
    Cavalcante RB; Lopes FF; Ferreira AS; Freitas Rde A; de Souza LB
    Braz Dent J; 2007; 18(3):192-7. PubMed ID: 18176708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoepithelial cell markers in salivary gland neoplasms.
    Furuse C; Sousa SO; Nunes FD; Magalhães MH; Araújo VC
    Int J Surg Pathol; 2005 Jan; 13(1):57-65. PubMed ID: 15735856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of alpha vascular smooth-muscle actin in salivary gland tumors.
    Hirano T; Gluckman JL; deVries EJ
    Arch Otolaryngol Head Neck Surg; 1990 Jun; 116(6):692-6. PubMed ID: 1692711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin and E-cadherin expression in salivary gland tumors.
    Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of immunohistochemistry to the diagnosis of salivary gland tumors.
    de Araújo VC; de Sousa SO; Carvalho YR; de Araújo NS
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):195-202. PubMed ID: 10981871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
    Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
    Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.
    Rosa JC; Félix A; Fonseca I; Soares J
    J Clin Pathol; 1997 Aug; 50(8):661-3. PubMed ID: 9301549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of different keratins in salivary gland tumours.
    de Araújo VC; de Sousa SO
    Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):14-8. PubMed ID: 8729613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K5/K14-positive cells contribute to salivary gland-like breast tumors with myoepithelial differentiation.
    Boecker W; Stenman G; Loening T; Andersson MK; Bankfalvi A; von Holstein S; Heegaard S; Lange A; Berg T; Samoilova V; Tiemann K; Buchwalow I
    Mod Pathol; 2013 Aug; 26(8):1086-100. PubMed ID: 23558567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin is a novel myoepithelial cell marker in pleomorphic adenoma and other salivary gland tumors with myoepithelial differentiation.
    Tsuneki M; Maruyama S; Yamazaki M; Essa A; Abé T; Babkair HA; Ahsan MS; Cheng J; Saku T
    Virchows Arch; 2013 Mar; 462(3):297-305. PubMed ID: 23262786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases.
    Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S
    Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of keratin, vimentin and myosin in salivary gland tumors.
    Matsushima R; Nakayama I; Shimizu M
    Acta Pathol Jpn; 1988 Apr; 38(4):445-54. PubMed ID: 2456668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and neoplastic myoepithelial cells in salivary glands: an immunohistochemical study.
    Morinaga S; Nakajima T; Shimosato Y
    Hum Pathol; 1987 Dec; 18(12):1218-26. PubMed ID: 2824327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant myoepithelioma of the minor salivary glands arising in a pleomorphic adenoma.
    Tralongo V; Rodolico V; Burruano F; Tortorici S; Mancuso A; Daniele E
    Anticancer Res; 1997; 17(4A):2671-5. PubMed ID: 9252699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metallothionein expression and its significance in salivary gland tumors].
    Gao Y; Han Z; Liu X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Sep; 32(5):282-4. PubMed ID: 11189287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin.
    Prabhu S; Kaveri H; Rekha K
    Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.